McKesson to Acquire 49% Stake in Option Care Health in $5.8B Buyout Deal

McKesson Corporation, in partnership with private equity firm Clayton, Dubilier & Rice (CD&R), announced a definitive agreement to acquire Option Care Health, a national provider of home and alternate site infusion services. The all-cash transaction has a total enterprise value of approximately $5.8 billion.

Key Details

• Transaction Value: The acquisition is valued at $32.05 per share, representing a total enterprise value of approximately $5.8 billion and a 37% premium to Option Care Health's prior-day closing price.
• Ownership & Investment: McKesson will invest approximately $1.4 billion to acquire a 49% minority interest, while CD&R will hold the remaining 51% majority stake.
• Post-Transaction Structure: Upon completion, Option Care Health will become a privately held company, de-listing from the Nasdaq, but will continue to operate as a separate company led by its own management team.
• Timeline: The deal is expected to close in the first half of calendar year 2027, subject to approval by Option Care Health's stockholders and regulatory approvals.